Those ever-present TV drug ads showing patients hiking, biking or enjoying a day at the beach could soon have a different ...

The move places the company in competition with other direct-to-consumer marketplaces including Hims & Hers Health and Ro.

Hims & Hers (HIMS) is down -17.7%, or -$4.88 to $22.72. Published first on TheFly – the ultimate source for real-time, ...

Amazon (AMZN) has been steadily expanding into healthcare, and now it’s setting its sights on telehealth companies like Hims ...

BofA lowered its rating of Hims & Hers (HIMS) to underperform from buy, citing Amazon’s (AMZN) push into the hair loss and ...

Amazon One Medical is expanding its telehealth services with the launch of upfront and low-cost treatment plans and ...

Shares of Hims & Hers Health slumped 15% on Thursday after Amazon.com launched a rival service that offers upfront pricing ...

FDA’s requirement for truthful, balanced risk and benefit information applies to drugmakers, leaving a loophole for both ...

Hims & Hers Health Inc (NYSE:HIMS) shares are trading lower in possible response to Amazon.com Inc's (NASDAQ:AMZN) new ...

Hims & Hers (HIMS) fell 17% Thursday after Amazon (AMZN) announced it was launching an expanded pay-per-visit telehealth ...

The tech giant said it would offer upfront, monthly pricing for customers seeking consultations and medications for five ...